You searched for "protection"
Artificial intelligence and OSA
The future’s bright, the future’s Orange AI… If you Google ‘how much is AI worth?’, the AI overview tells you “The global artificial intelligence (AI) market size is estimated at approximately $244 billion to $391 billion in 2025 and is...Young CEORL-HNS: growing a pan-European ENT network
We are seeing a growth in the number of organisations supporting young ENT surgeons. Young CEORL-HNS is a thriving and expanding group. The Young Confederation of European ORL-HNS (Y-CEORL) was created with a simple idea in mind: to give young...
Do you use the evidence or do you just know to do that?
In this day and age we generally consider healthcare practice to be evidence-based. Unfortunately there are not always the plethora of research articles available that address the dilemmas of day-to-day clinical practice. This piece of work considers what factors influence...Breakthrough tinnitus device Lenire available in three new clinics in Spain
Neuromod has announced that clinically proven tinnitus treatment device, Lenire, is now available in Malaga, Seville and Granada through partnership with medical technology distributor, TRUSBIN.Embrace the blue wave of ENT!
Introducing MEDENCY, an Italian company in advanced medical technology.
We all need to support the human rights of people with communication difficulties
This article starts by reminding us of the Universal Declaration of Human Rights (United Nations, 1948) of which article 19 stated: ‘‘Everyone has the right to freedom of opinion and expression; this right includes freedom to hold opinions without interference...
Can amplification preserve auditory function?
Hearing loss is a noted modifiable risk factor for dementia, and is also associated with depression, decreased quality of life and isolation. Hearing aids are the main intervention for presbycusis and a 2017 Cochrane Review showed that they have a...
Bevacizumab, NF2, hearing and age
Introduction NF2-related schwannomatosis (NF2-SWN) is an autosomal dominant disorder leading to the development of schwannomas, meningiomas and spinal cord ependymomas. Younger age is a negative prognostic factor. Treatment includes observation, surgery, radiotherapy and medical therapy with bevacizumab (VEGF monoclonal antibody)....MedAudPro: a united front for audiology
For the past three years, the Network of Medical Audiology Professionals has been bringing together ENT providers in the USA. Co-founder and President, Patricia Ramos talks about her ambitions for the organisation.Cochlear implantation for single-sided deafness and asymmetric hearing loss
Continuing our sub-theme of cochlear implantation candidacy, Richard Irving and Raghu Kumar review the principles and benefits of cochlear implantation in individuals who have an asymmetric hearing loss. It is well known that cochlear implantation improves auditory capacity, and in...OBITUARY: David Moffat (1948-2020)
David Moffat, one of the leading Otologists of his generation, died on 18 March in Addenbrooke’s Hospital in Cambridge, the hospital to which he had devoted his professional life. Having survived cancer of the prostate, he succumbed to a second...
